Advanced Health Limited provided earnings guidance for the year ended 30 June 2021. The directors of Advanced Health hereby advise shareholders that, in respect of the reviewed consolidated results for the year ended 30 June 2021, the Company expects a loss per share ranging between 4.17 cents and 6.25 cents, compared to a loss per share of 51.08 cents for the comparative year ended 30 June 2020. This equates to an improvement of between 88% and 92%. The headline loss per share for the year ended 30 June 2021 is expected to range between 1.68 cents and 2.52 cents, compared to a headline loss per share of 49.42 cents for the comparative year ended 30 June 2020. This equates to an improvement of between 95% to 97%.